As Attached

Date: 23 July 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL Dear Sir/Madam, This is further to our letter dated July 23, 2026, intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2026. We wish to inform that pursuant to Regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Wednesday, July 29, 2026, at 04:30 P.M. IST. The details of the said call are attached herewith and are also available on Company’s website. Thank you. For Eris Lifesciences Limited Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493 Encl.: a/a Eris Lifesciences Limited Q1 FY2027 Earnings Call Invite Day/Date: Wednesday, 29th July 2026 Time: 4:30 PM, IST To join the call through Zoom: Please pre-register by clicking here or copy and paste the following link in your browser https://zoom.us/webinar/register/WN_AH5SYmDJSu6TzrMoYbS9pg We look forward to your participation Atul Modi RSV P : Investor Relations https://eris.co.in/ atul.modi@eristherapeutics.com